175 related articles for article (PubMed ID: 26892504)
1. Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex.
Lin YL; Chen CH; Wu HY; Tsai NM; Jian TY; Chang YC; Lin CH; Wu CH; Hsu FT; Leung TK; Liao KW
J Nanobiotechnology; 2016 Feb; 14():11. PubMed ID: 26892504
[TBL] [Abstract][Full Text] [Related]
2. Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.
Lin YL; Tsai NM; Chen CH; Liu YK; Lee CJ; Chan YL; Wang YS; Chang YC; Lin CH; Huang TH; Wang CC; Chi KH; Liao KW
J Nanobiotechnology; 2019 Feb; 17(1):25. PubMed ID: 30728015
[TBL] [Abstract][Full Text] [Related]
3. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells.
Lin YL; Liu YK; Tsai NM; Hsieh JH; Chen CH; Lin CM; Liao KW
Nanomedicine; 2012 Apr; 8(3):318-27. PubMed ID: 21704596
[TBL] [Abstract][Full Text] [Related]
4. Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.
Lin YL; Chang KF; Huang XF; Hung CL; Chen SC; Chao WR; Liao KW; Tsai NM
Int J Nanomedicine; 2015; 10():6009-20. PubMed ID: 26451107
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of cytotoxicity and induction of apoptosis by cationic nano-liposome formulation of
Huang XF; Chang KF; Lin YL; Liao KW; Hsiao CY; Sheu GT; Tsai NM
Int J Med Sci; 2021; 18(13):2930-2942. PubMed ID: 34220320
[TBL] [Abstract][Full Text] [Related]
6. iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity.
Diaz Bessone MI; Simón-Gracia L; Scodeller P; Ramirez MLA; Lago Huvelle MA; Soler-Illia GJAA; Simian M
J Nanobiotechnology; 2019 Dec; 17(1):120. PubMed ID: 31812165
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
Chen JL; Chang CJ; Wang JY; Wen CS; Tseng LM; Chang WC; Noomhorm N; Liu HJ; Chen WS; Chiu JH; Shyr YM
Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.
Jain AS; Goel PN; Shah SM; Dhawan VV; Nikam Y; Gude RP; Nagarsenker MS
Biomed Pharmacother; 2014 May; 68(4):429-38. PubMed ID: 24721327
[TBL] [Abstract][Full Text] [Related]
9. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
[TBL] [Abstract][Full Text] [Related]
10. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Osipo C; Gajdos C; Cheng D; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Effect of
Gao HW; Chang KF; Huang XF; Lin YL; Weng JC; Liao KW; Tsai NM
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563276
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL; Wang JY; Tsai YF; Lin YH; Tseng LM; Chang WC; King KL; Chen WS; Chiu JH; Shyr YM
Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
[TBL] [Abstract][Full Text] [Related]
13. Encapsulated
Lin YL; Huang XF; Chang KF; Liao KW; Tsai NM
Int J Nanomedicine; 2020; 15():749-760. PubMed ID: 32099363
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
16. A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against Luminal A breast cancer.
Wang X; Chen X; Yang X; Gao W; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Dai Z; Zhang Q
Nanomedicine; 2016 Feb; 12(2):387-97. PubMed ID: 26711969
[TBL] [Abstract][Full Text] [Related]
17. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
Chen J; Hui E; Ip T; Thompson LU
Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
[TBL] [Abstract][Full Text] [Related]
18. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Characterization of PLGA-PEG-PLGA Nanoparticles Containing Salidroside and Tamoxifen for Breast Cancer Therapy.
Yu X; Sun L; Tan L; Wang M; Ren X; Pi J; Jiang M; Li N
AAPS PharmSciTech; 2020 Jan; 21(3):85. PubMed ID: 31997020
[TBL] [Abstract][Full Text] [Related]
20. Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice.
Sacco SM; Power KA; Chen J; Ward WE; Thompson LU
Exp Biol Med (Maywood); 2007 Jun; 232(6):754-61. PubMed ID: 17526767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
